Continued Revenue Growth Leads to Strong Income Growth
Company Reiterates 2017 Guidance
Company Announces Key Executive Transitions
Company to Host Conference Call Today at 8:30 a.m. EST
ROCKVILLE, Md., March 08, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today reported consolidated financial results for the fourth quarter and full year ended December 31, 2016.
Additionally, today Sucampo ann
RelSci News & Alerts gets you: